Thaker, Premal H <br/><br/>
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 2005 
 - 4923-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-2060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Blood Vessels--drug effects<br/>Blotting, Western<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred CBA<br/>Mice, Nude<br/>Ovarian Neoplasms--blood supply<br/>Paclitaxel--administration & dosage<br/>Platelet Endothelial Cell Adhesion Molecule-1--analysis<br/>Proliferating Cell Nuclear Antigen--analysis<br/>Purines--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays--methods